103188-49-4 (香豆酸多巴胺,(E)-N-(3,4-Dihydroxyphenethyl)-3-(3,4-dihydroxyphenyl)acrylamide)

1,3,5-三(2-噻吩基)苯;咖啡酸多巴胺;咖啡酰多巴胺;N-咖啡酰多巴胺;香豆酸多巴胺;(E)-3-(3,4-二羟基苯基)-N-[2-(3,4-二羟基苯基)乙基]-2-丙烯酰胺;

(E)-N-(3,4-Dihydroxyphenethyl)-3-(3,4-dihydroxyphenyl)acrylamide;2E)-3-(3,4-Dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]acrylamide;3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]prop-2-enamide;N-(3,4-dihydroxyphenethyl)-3-(3,4-dihydroxyphenyl)acrylamide;N-caffeoyldopamine;N-trans-caffeoyldopamine;(e)-3-(3;Caffenoyldopamine;4-dihydroxyphenyl)-n-(2-(3;(e)-3-(3,4-dihydroxyphenyl)-n-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenaMide;4-dihydroxyphenyl)ethyl)-2-propenaMide;(2E)-3-(3,4-Dihydroxyphenyl)-N-(2-(3,4-dihydroxyphenyl)ethyl)-2-propenamide;P-coumaric acid derivative 2;CHEMBL68132;SCHEMBL109066;caffeoyldopamine;A-IN-9;(E)-3-(3,4-dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]prop-2-enamide;AKOS016012370;CS-1072636;BS-14192;A;C14041;AC-26418;Caffedymine;103188-49-4;UNII-HEM1G2VY70;BDBM50276918;2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-(2-(3,4-dihydroxyphenyl)ethyl)-, (2E)-;105955-00-8;2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-(2-(3,4-dihydroxyphenyl)ethyl)-;HEM1G2VY70;CS-0186103;Z1625563034;

MFCD17129090

FSMGGLPUXCKRGT-ZZXKWVIFSA-N

1S/C17H17NO5/c19-13-4-1-11(9-15(13)21)3-6-17(23)18-8-7-12-2-5-14(20)16(22)10-12/h1-6,9-10,19-22H,7-8H2,(H,18,23)/b6-3+

OC1C(O)=CC(CCNC(/C=C/C2C=C(O)C(O)=CC=2)=O)=CC=1

2924299090